Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network
Open Access
- 23 August 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (38) , 62460-62473
Abstract
Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory networkKeywords
This publication has 38 references indexed in Scilit:
- Pristimerin Causes G1 Arrest, Induces Apoptosis, and Enhances the Chemosensitivity to Gemcitabine in Pancreatic Cancer CellsPLOS ONE, 2012
- Dihydroartemisinin Enhances Apo2L/TRAIL-Mediated Apoptosis in Pancreatic Cancer Cells via ROS-Mediated Up-Regulation of Death Receptor 5PLOS ONE, 2012
- Cdc42 in oncogenic transformation, invasion, and tumorigenesisCellular Signalling, 2011
- MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory PathwaysGenes & Cancer, 2010
- Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivoCancer Letters, 2010
- Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-κBJournal of Cancer Research and Clinical Oncology, 2009
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nature Reviews Genetics, 2008
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005
- MicroRNAsCell, 2004
- Rho GTPases in cell biologyNature, 2002